8-KOther Events

JOHNSON & JOHNSON 8-K Report (Mar 12, 2003)

Filed March 12, 2003For Securities:JNJ

Summary

This Form 8-K filing by Johnson & Johnson (JNJ) on March 12, 2003, serves to attach significant financial information related to their 2002 fiscal year. Specifically, the company is incorporating by reference its audited consolidated financial statements as of December 29, 2002, and December 30, 2001, along with the financial results for the three years ended December 29, 2002. This also includes the Management's Discussion and Analysis (MD&A) section and the independent accountant's report, all of which are provided as Exhibit 99.15. For investors, this filing is crucial as it provides audited financial data that forms the basis for understanding the company's financial health, performance trends, and management's perspective on the business. The inclusion of the MD&A is particularly valuable for insights into the factors driving results, potential risks, and future outlook. Investors should review these attached financial statements and accompanying discussions to assess J&J's financial standing and operational performance for the period.

Key Highlights

  • 1Johnson & Johnson (JNJ) filed an 8-K report on March 12, 2003.
  • 2The filing incorporates by reference the audited consolidated financial statements for the years ending December 29, 2002, and December 30, 2001.
  • 3Financial results for the three-year period ending December 29, 2002, are included.
  • 4The Management's Discussion and Analysis (MD&A) of Financial Condition and Results of Operations is part of the filing.
  • 5The independent accountant's report is also included as part of Exhibit 99.15.
  • 6Exhibit 99.15 contains the audited consolidated financial statements for the period ended December 29, 2002.
  • 7Stephen J. Cosgrove, Chief Accounting Officer, signed the report on behalf of Johnson & Johnson.

Frequently Asked Questions

The primary purpose of this 8-K filing is to provide investors with access to Johnson & Johnson's audited consolidated financial statements for the fiscal years ending December 29, 2002, and December 30, 2001, as well as the financial results for the preceding three-year period. It also includes the Management's Discussion and Analysis and the independent accountant's report.

The detailed financial information, including the audited consolidated financial statements, Management's Discussion and Analysis, and the independent accountant's report, is incorporated by reference as Exhibit 99.15 to this Form 8-K filing.

The audited consolidated financial statements cover the periods as of December 29, 2002, and December 30, 2001, and for each of the years in the three-year period ended December 29, 2002.

Stephen J. Cosgrove is the Chief Accounting Officer of Johnson & Johnson. He signed the report on behalf of the company, indicating his authorization and responsibility for the accuracy of the filing.